INSIGHTS ON DRUG DEVELOPMENT
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
Building A Human-Centric Future For Biologics Development
Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.
-
Quantification Of Exenatide Using Xevo TQD
Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.
-
Accelerating Small Molecule Development With Cutting-Edge Technology
Discover Asymchem Sandwich, our advanced small molecule facility at Discovery Park, Kent.
-
Technology-Led Expansion Of Oligonucleotide Capabilities4/13/2026
Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue5/6/2026
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and deārisk innovative programs through early dialogue.
-
Scale-Up Of An Adherent rAAV Production Process11/3/2025
Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.
-
From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development3/8/2026
See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.
DRUG DEVELOPMENT SOLUTIONS
-
Flow cytometry is a powerful and versatile technique to analyze the physical and chemical characteristics of cells or particles.
-
In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.
-
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
Our HPAPI development and manufacturing spans preclinical through commercial supply across 13 global sites, with SafeBridge-certified containment and 30 years of cytotoxic compound expertise.
-
Discover purpose-built lab tools that combine intuitive design, dependable performance, and accessible cost to support fast, confident scientific work.